Literature DB >> 18533279

Susceptibility to chronic inflammatory demyelinating polyradiculoneuropathy is associated to polymorphic GA repeat in the SH2D2A gene.

Francesca Notturno1, Marta Pace, Maria V De Angelis, Christina M Caporale, Armando Giovannini, Antonino Uncini.   

Abstract

The SH2D2A gene encodes a T-cell-specific adapter protein involved in the negative control of T-cell activation. The genotype GA13-16 homozygote of the SH2D2A gene promoter has been associated with the susceptibility to develop multiple sclerosis. Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an immune-mediated neuropathy sharing several pathogenetic mechanisms with multiple sclerosis. We genotyped the SH2D2A promoter region in 105 controls and 48 patients with CIDP. We found a significant association between CIDP and the genotype GA13-16 homozygote (OR 3.167; p 0.013). We hypothesize that this genotype is associated with the susceptibility to develop CIDP and may be implicated in the persistence of the disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18533279     DOI: 10.1016/j.jneuroim.2008.04.003

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  4 in total

Review 1.  Advances in the diagnosis, pathogenesis and treatment of CIDP.

Authors:  Marinos C Dalakas
Journal:  Nat Rev Neurol       Date:  2011-08-16       Impact factor: 42.937

Review 2.  The immune response and aging in chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  Kathleen M Hagen; Shalina S Ousman
Journal:  J Neuroinflammation       Date:  2021-03-22       Impact factor: 8.322

3.  Genome-Wide Association Analysis Reveals Genetic Heterogeneity of Sjögren's Syndrome According to Ancestry.

Authors:  Kimberly E Taylor; Quenna Wong; David M Levine; Caitlin McHugh; Cathy Laurie; Kimberly Doheny; Mi Y Lam; Alan N Baer; Stephen Challacombe; Hector Lanfranchi; Morten Schiødt; M Srinivasan; Hisanori Umehara; Frederick B Vivino; Yan Zhao; Stephen C Shiboski; Troy E Daniels; John S Greenspan; Caroline H Shiboski; Lindsey A Criswell
Journal:  Arthritis Rheumatol       Date:  2017-05-09       Impact factor: 10.995

Review 4.  Susceptible loci associated with autoimmune disease as potential biomarkers for checkpoint inhibitor-induced immune-related adverse events.

Authors:  Esmée P Hoefsmit; Elisa A Rozeman; John B A G Haanen; Christian U Blank
Journal:  ESMO Open       Date:  2019-07-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.